Why Is First Wave BioPharma (FWBI) Stock Up Today?

First Wave BioPharma (NASDAQ:FWBI) stock is heading higher on Thursday after the clinical-stage biopharmaceutical company completed its business combination with ImmunogenX.First Wave BioPharma used an all-stock transaction to acquire ImmunogenX. Of major interest of the company is latiglutenase. This is a oral biotherapeutic for celiac disease.First Wave BioPharma is excited about the potential of latiglutenase as it could be a first-in-class treatment. The company also notes that the drug is already close ...